Major news and media outlets have today highlighted the Food Standards Authority (FSA) official announcement on ingestible CBD products in the UK. The FSA has stated that all businesses selling ingestible forms of CBD such as CBD in food or oils, must apply for a Novel Foods Permit by March 2021. Additionally, the FSA warned that those who are pregnant or breastfeeding should avoid CBD products – something which we have always made very clear.
Many in the media have chosen to use this announcement to paint the CBD industry in a negative light, with some suggesting this is the end of the CBD industry as a whole and that all products will be removed from store shelves following the deadline for Novel Foods application. This is fear-mongering, similar to the recent ‘vape fiasco’ and is largely untrue. However, this is certainly a step towards tighter regulation which is ultimately good for consumer protection.
We have expected, for a long while that the FSA would take this position and at Dr. Ed we are taking their announcement as a positive development for the industry. Most of our readers and customers are well aware that we champion safety and regulation in the CBD/Cannabis market and while some may claim this announcement is unduly harsh, it aims to place consumer safety at the forefront of thinking. Overall this will greatly increase the quality of CBD products available for purchase in retail stores.
Here are the facts about the announcement:
I would like to take this opportunity to assure our consumers that we are industry leading when it comes to how we make our CBD products. From the raw ingredients we source, to our mixing processes, analytics and labelling accuracy; we strive to be the most transparent and informative CBD company around. The suppliers in our production chain who need to apply for a Novel Food License already have or are in the process of doing so. If anyone would like to speak to our team or myself directly about this announcement please do not hesitate to reach out.